Find a Doctor - Search by last name or narrow your search by gender or languages spoken
Find a Location - Search by specialty, city, or state
Secondary adrenocortical insufficiency is a condition in which a deficiency of adrenocorticotropic hormone (ACTH) leads to insufficient cortisol production.
Production of cortisol is controlled by the action of ACTH produced by the pituitary gland. The pituitary gland is regulated by the hypothalamus in the brain. If either the hypothalamus or pituitary gland is damaged, less ACTH is produced, leading to underfunctioning of the adrenal glands and reduced cortisol production.
This may be caused by:
The symptoms of secondary adrenocortical insufficiency are similar to those of Addison's disease, except that darkening of the skin (hyperpigmentation) and high levels of potassium in the blood are not present.
With secondary adrenocortical insufficiency, only cortisol is low. The adrenal glands can still make normal amounts of aldosterone. Symptoms include:
Diagnosis starts with a medical history and physical examination. If your doctor suspects adrenal insufficiency, he or she will check your blood cortisol and ACTH levels. Your doctor may recommend imaging tests of the adrenal glands, the pituitary gland, or the hypothalamus.
If your doctor suspects secondary adrenocortical insufficiency, you may get infusions of ACTH on two consecutive days. In most cases, even if you have problems with the pituitary or hypothalamus, your adrenal glands will make cortisol by the end of the second treatment. If possible, your doctor will treat the condition that is causing secondary adrenocortical insufficiency. Your doctor may start treatment during the testing if he or she thinks adrenal insufficiency is likely. If treatment is found to be unnecessary, it can be stopped after testing is complete.
CT scan or MRI can be used to see whether there is evidence of damage to the brain or pituitary gland (such as a tumor) that is causing adrenal failure.
Other Works Consulted
- Hughes JM (2011). Adrenocortical insufficiency. In ET Bope et al., eds., Conn’s Current Therapy 2011, pp. 651–653. Philadelphia: Saunders.
| By | Healthwise Staff |
|---|---|
| Primary Medical Reviewer | E. Gregory Thompson, MD - Internal Medicine |
| Specialist Medical Reviewer | David C.W. Lau, MD, PhD, FRCPC - Endocrinology |
| Last Revised | December 5, 2011 |
Next Section:
Related InformationPrevious Section:
Topic OverviewNext Section:
ReferencesPrevious Section:
Related InformationNext Section:
CreditsPrevious Section:
ReferencesLast Revised: December 5, 2011
Author: Healthwise Staff
Medical Review: E. Gregory Thompson, MD - Internal Medicine & David C.W. Lau, MD, PhD, FRCPC - Endocrinology
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT@sanfordjayne: @CorporateCup @SanfordHealth Can't wait to compete at the FMWF Chamber Corporate Cup. Go TEAM Sanford!!!